|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.80 CHF | -0.55% |
|
+1.75% | +61.76% |
| 12-05 | Swiss Market Index Concludes Week Upbeat; Swiss Re Shares Drop | MT |
| 12-05 | Galderma's Regenerative Biostimulator Sculptra Gets EU Certification for Body Indication | MT |
| Capitalization | 48B 41.26B 38.65B 36.02B 66.54B 4,320B 72.37B 452B 175B 2,040B 180B 176B 7,459B | P/E ratio 2025 * |
97x | P/E ratio 2026 * | 55.5x |
|---|---|---|---|---|---|
| Enterprise value | 50.01B 42.99B 40.27B 37.54B 69.33B 4,501B 75.41B 471B 182B 2,126B 188B 184B 7,772B | EV / Sales 2025 * |
9.46x | EV / Sales 2026 * | 7.92x |
| Free-Float |
35.38% | Yield 2025 * |
0.15% | Yield 2026 * | 0.28% |
Last Transcript: Galderma Group AG
| 1 day | -0.55% | ||
| 1 week | +1.75% | ||
| Current month | +1.75% | ||
| 1 month | +10.00% | ||
| 3 months | +12.51% | ||
| 6 months | +40.47% | ||
| Current year | +61.76% |
| 1 week | 156.3 |  | 165.8 |
| 1 month | 143 | | 165.8 |
| Current year | 72.7 | | 165.8 |
| 1 year | 72.7 | | 165.8 |
| 3 years | 60 | | 165.8 |
| 5 years | 60 | | 165.8 |
| 10 years | 60 | | 165.8 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.55% | +1.75% | +85.48% | - | 48B | |
| +1.07% | -0.76% | +8.48% | +3.84% | 231B | |
| +0.02% | -1.47% | -5.91% | +13.52% | 18.11B | |
| +2.38% | +5.58% | -14.23% | -62.37% | 6.03B | |
| +0.24% | 0.00% | +20.91% | -7.93% | 5.27B | |
| -0.27% | +6.87% | -41.69% | +48.51% | 4.85B | |
| -1.14% | -0.63% | +147.50% | - | 4.42B | |
| +0.03% | -1.83% | -25.11% | -42.52% | 3.85B | |
| +1.77% | +3.92% | -54.66% | -56.60% | 3.02B | |
| +0.75% | +1.82% | -39.36% | -15.95% | 2.65B | |
| Average | +0.43% | +1.40% | +8.14% | -14.94% | 32.74B | |
| Weighted average by Cap. | +0.73% | -0.15% | +18.53% | +2.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.2B 4.47B 4.19B 3.9B 7.21B 468B 7.84B 48.96B 18.9B 221B 19.51B 19.09B 808B | 6.17B 5.3B 4.97B 4.63B 8.55B 555B 9.3B 58.11B 22.44B 262B 23.16B 22.66B 959B |
| Net income | 544M 468M 438M 408M 754M 48.95B 820M 5.12B 1.98B 23.12B 2.04B 2B 84.53B | 901M 775M 726M 677M 1.25B 81.12B 1.36B 8.49B 3.28B 38.31B 3.38B 3.31B 140B |
| Net Debt | 2.01B 1.73B 1.62B 1.51B 2.79B 181B 3.04B 18.96B 7.32B 85.56B 7.55B 7.39B 313B | 1.25B 1.07B 1.01B 939M 1.73B 113B 1.89B 11.78B 4.55B 53.15B 4.69B 4.59B 194B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 162.80 CHF | -0.55% | 296,756 |
| 04/12/25 | 163.70 CHF | +0.31% | 269,021 |
| 03/12/25 | 163.20 CHF | +3.23% | 306,917 |
| 02/12/25 | 158.10 CHF | 0.00% | 268,603 |
| 01/12/25 | 158.10 CHF | -1.19% | 322,280 |
Delayed Quote Swiss Exchange, December 05, 2025 at 08:30 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GALD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition